New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies
- PMID: 22551678
- DOI: 10.1016/j.ejmech.2012.03.050
New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies
Abstract
Two groups of hybrid compounds: the quinazolinone-dihydropyrimidines and quinazolinone-pyrimidines, were synthesized. The starting derivative 3 was reacted with chloroacetyl chloride to give intermediate 5 which was condensed with the 2-mercaptopyrimidines 4a-c affording compounds 6a-c. These latter compounds underwent hydrolysis and N-alkylation reactions to give the dihydropyrimidine derivatives 7a-c and 8a-f, respectively. The chloro derivatives 9a-c subsequently reacted with various anilines furnishing compounds 10a-i. The anti-inflammatory activity of the synthesized compounds were evaluated using the carrageenan-induced rat paw oedema model and ulcer indices for the most active compounds were calculated. Five compounds were found more active and less ulcerogenic than diclofenac particularly compound 10 g (IC(50) = 116.73 μmol/kg; ulcer index = 11.38). Compound 10 g was also 2-fold more selective inhibitor of COX-2 than COX-1.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives.Eur J Med Chem. 2010 Jul;45(7):3147-54. doi: 10.1016/j.ejmech.2010.04.005. Epub 2010 Apr 14. Eur J Med Chem. 2010. PMID: 20444529
-
New pyrimido[5,4-e]pyrrolo[1,2-c]pyrimidines: synthesis, 2D-QSAR, anti-inflammatory, analgesic and ulcerogenicity studies.Eur J Med Chem. 2012 Sep;55:12-22. doi: 10.1016/j.ejmech.2012.06.048. Epub 2012 Jul 4. Eur J Med Chem. 2012. PMID: 22818041
-
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.J Enzyme Inhib Med Chem. 2016;31(sup2):6-12. doi: 10.1080/14756366.2016.1186018. Epub 2016 May 22. J Enzyme Inhib Med Chem. 2016. PMID: 27210522
-
Heterocyclic compounds as inflammation inhibitors.Curr Med Chem. 2002 May;9(10):1045-74. doi: 10.2174/0929867024606678. Curr Med Chem. 2002. PMID: 12733983 Review.
-
Recent advances in the synthesis of 2,3-fused quinazolinones.Org Biomol Chem. 2022 Aug 17;20(32):6293-6313. doi: 10.1039/d2ob00778a. Org Biomol Chem. 2022. PMID: 35838160 Review.
Cited by
-
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.Eur J Med Chem. 2021 Feb 15;212:113125. doi: 10.1016/j.ejmech.2020.113125. Epub 2020 Dec 31. Eur J Med Chem. 2021. PMID: 33422981 Free PMC article.
-
Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity.Molecules. 2017 Dec 21;23(1):8. doi: 10.3390/molecules23010008. Molecules. 2017. PMID: 29267237 Free PMC article.
-
Synthesis, antitumor activity, 3D-QSAR and molecular docking studies of new iodinated 4-(3H)-quinazolinones 3N-substituted.RSC Adv. 2022 Aug 2;12(33):21340-21352. doi: 10.1039/d2ra03684c. eCollection 2022 Jul 21. RSC Adv. 2022. PMID: 35975048 Free PMC article.
-
Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review.Curr Top Med Chem. 2025;25(9):1032-1068. doi: 10.2174/0115680266317088240924205745. Curr Top Med Chem. 2025. PMID: 39410888 Review.
-
Synthesis and PASS-assisted in silico approach of some novel 2-substituted benzimidazole bearing a pyrimidine-2, 4, 6(trione) system as mucomembranous protector.J Pharm Bioallied Sci. 2013 Jan;5(1):39-43. doi: 10.4103/0975-7406.106563. J Pharm Bioallied Sci. 2013. PMID: 23559822 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials